Status:
RECRUITING
Optimization of Minocycline for Helicobacter Pylori Rescue Treatment
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The efficacy of bismuth-containing quadruple therapy with minocycline and metronidazole was not inferior to classical bismuth quadruple therapy for refractory H. pylori infection, though also accompan...
Eligibility Criteria
Inclusion
- Ability and willingness to participate in the study and to sign and give informed consent
- Confirmed H. pylori infection and with previous treatment experience
Exclusion
- subjects naive to H. pylori treatment,
- under 18 or over 80 years old
- history of gastrectomy
- pregnant or lactating women
- Previous history of tuberculosis
- Allergy to any of the study drugs
- severe systemic diseases or malignancy
- administration of antibiotics, bismuth, antisecretory drugs, or Chinese herb medicine in the preceding 8 weeks
Key Trial Info
Start Date :
August 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
476 Patients enrolled
Trial Details
Trial ID
NCT06561711
Start Date
August 21 2024
End Date
August 30 2026
Last Update
December 30 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
2
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200127
3
Songjiang Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China
4
The Second Affiliated Hospital of Zhejiang University school of Medicine
Hangzhou, Zhejiang, China